Literature DB >> 6740094

Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.

E E Lasch, Y Abed, K Abdulla, A G El Tibbi, O Marcus, M El Massri, R Handscher, C B Gerichter, J L Melnick.   

Abstract

Trivalent oral poliovirus vaccine ( TOPV ) has been used in Gaza since 1967. After an initial decrease of 33% in the incidence of the paralytic disease, no further decrease could be noted. The mean annual incidence until 1977 was 10 per 100,000 inhabitants. Two outbreaks caused by poliovirus type 1 were registered in 1974 and 1976 with an incidence of 18 per 100,000 inhabitants. In these outbreaks, 34% and 50% of the affected children, respectively, had received three to four doses of TOPV . A new vaccination schedule was introduced in 1978, combining live and inactivated poliovirus vaccines. In the years 1978-1980, the incidence decreased to 2.6 per 100,000 inhabitants; and during 1981-1982, only three cases were recorded. These results indicate that a schedule like the one used in Gaza could serve as a model to control poliomyelitis in developing countries where TOPV alone is not successful.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740094     DOI: 10.1093/clinids/6.supplement_2.s467

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

Review 1.  Poliomyelitis: eradication in sight.

Authors:  J L Melnick
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

2.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Authors:  T Tulchinsky; Y Abed; S Shaheen; N Toubassi; Y Sever; M Schoenbaum; R Handsher
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

Review 3.  Current status of poliovirus infections.

Authors:  J L Melnick
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

4.  Vaccination against poliomyelitis: present possibilities and future prospects.

Authors:  J L Melnick
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

5.  Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.

Authors:  N Deivanayagam; K Nedunchelian; S S Ahamed; S R Rathnam
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

6.  Controversies in polio immunization.

Authors:  Naveen Thacker; Niranjan Shendurnikar
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

Review 7.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 8.  Future of polio vaccines.

Authors:  Ellie Ehrenfeld; John Modlin; Konstantin Chumakov
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

Review 9.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.